{
    "2019-07-16": [
        [
            {
                "time": "2023-10-18",
                "original_text": "Top Research Reports for Berkshire Hathaway, Pfizer & Danaher",
                "features": {
                    "keywords": [
                        "Berkshire Hathaway",
                        "Pfizer",
                        "Danaher",
                        "research reports"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "finance",
                        "healthcare",
                        "industrial"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-10-18",
                "original_text": "Will Danaher's (DHR) Products & Buyouts Drive Q2 Earnings?",
                "features": {
                    "keywords": [
                        "Danaher",
                        "Products",
                        "Buyouts",
                        "Q2 Earnings"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "industrial"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}